SNAI2 and gastric cancer: Previous study has reported that the expression of miR-203 was significantly lower in gastric cancer samples compared to non-cancerous samples, closely correlated with advanced stage and lymph node involvement23 and could suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/E-cadherin signaling24.